These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 26677230)
1. Nanobodies as Probes for Protein Dynamics in Vitro and in Cells. Dmitriev OY; Lutsenko S; Muyldermans S J Biol Chem; 2016 Feb; 291(8):3767-75. PubMed ID: 26677230 [TBL] [Abstract][Full Text] [Related]
2. Generation, expression and utilization of single-domain antibodies for in vivo protein localization and manipulation in sea urchin embryos. Schrankel CS; Gökirmak T; Lee CW; Chang G; Hamdoun A Methods Cell Biol; 2019; 151():353-376. PubMed ID: 30948018 [TBL] [Abstract][Full Text] [Related]
3. Screening and Characterization Strategies for Nanobodies Targeting Membrane Proteins. Veugelen S; Dewilde M; De Strooper B; Chávez-Gutiérrez L Methods Enzymol; 2017; 584():59-97. PubMed ID: 28065273 [TBL] [Abstract][Full Text] [Related]
4. Identification of conformation-selective nanobodies against the membrane protein insertase BamA by an integrated structural biology approach. Kaur H; Hartmann JB; Jakob RP; Zahn M; Zimmermann I; Maier T; Seeger MA; Hiller S J Biomol NMR; 2019 Jul; 73(6-7):375-384. PubMed ID: 31073665 [TBL] [Abstract][Full Text] [Related]
5. Production and Application of Nanobodies for Membrane Protein Structural Biology. Brunner JD; Schenck S Methods Mol Biol; 2020; 2127():167-184. PubMed ID: 32112322 [TBL] [Abstract][Full Text] [Related]
6. Modular transient nanoclustering of activated β2-adrenergic receptors revealed by single-molecule tracking of conformation-specific nanobodies. Gormal RS; Padmanabhan P; Kasula R; Bademosi AT; Coakley S; Giacomotto J; Blum A; Joensuu M; Wallis TP; Lo HP; Budnar S; Rae J; Ferguson C; Bastiani M; Thomas WG; Pardon E; Steyaert J; Yap AS; Goodhill GJ; Hilliard MA; Parton RG; Meunier FA Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30476-30487. PubMed ID: 33214152 [TBL] [Abstract][Full Text] [Related]
7. Mechanistic analysis of allosteric and non-allosteric effects arising from nanobody binding to two epitopes of the dihydrofolate reductase of Escherichia coli. Oyen D; Wechselberger R; Srinivasan V; Steyaert J; Barlow JN Biochim Biophys Acta; 2013 Oct; 1834(10):2147-57. PubMed ID: 23911607 [TBL] [Abstract][Full Text] [Related]
8. Direct Immobilization of Engineered Nanobodies on Gold Sensors. Simões B; Guedens WJ; Keene C; Kubiak-Ossowska K; Mulheran P; Kotowska AM; Scurr DJ; Alexander MR; Broisat A; Johnson S; Muyldermans S; Devoogdt N; Adriaensens P; Mendes PM ACS Appl Mater Interfaces; 2021 Apr; 13(15):17353-17360. PubMed ID: 33845569 [TBL] [Abstract][Full Text] [Related]
9. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics. Bannas P; Hambach J; Koch-Nolte F Front Immunol; 2017; 8():1603. PubMed ID: 29213270 [TBL] [Abstract][Full Text] [Related]
10. Nanobodies against the metal binding domains of ATP7B as tools to study copper transport in the cell. Uhlemann EE; Yu CH; Patry J; Dolgova N; Lutsenko S; Muyldermans S; Dmitriev OY Metallomics; 2020 Dec; 12(12):1941-1950. PubMed ID: 33094790 [TBL] [Abstract][Full Text] [Related]
11. Nanobodies to Study G Protein-Coupled Receptor Structure and Function. Manglik A; Kobilka BK; Steyaert J Annu Rev Pharmacol Toxicol; 2017 Jan; 57():19-37. PubMed ID: 27959623 [TBL] [Abstract][Full Text] [Related]
12. Exploring single-domain antibody thermostability by molecular dynamics simulation. Mohseni A; Molakarimi M; Taghdir M; Sajedi RH; Hasannia S J Biomol Struct Dyn; 2019 Sep; 37(14):3686-3696. PubMed ID: 30241448 [TBL] [Abstract][Full Text] [Related]
13. Development of Antibody and Nanobody Tools for P2X7. Stähler T; Danquah W; Demeules M; Gondé H; Hardet R; Haag F; Adriouch S; Koch-Nolte F; Menzel S Methods Mol Biol; 2022; 2510():99-127. PubMed ID: 35776322 [TBL] [Abstract][Full Text] [Related]
14. Institute collection and analysis of Nanobodies (iCAN): a comprehensive database and analysis platform for nanobodies. Zuo J; Li J; Zhang R; Xu L; Chen H; Jia X; Su Z; Zhao L; Huang X; Xie W BMC Genomics; 2017 Oct; 18(1):797. PubMed ID: 29041922 [TBL] [Abstract][Full Text] [Related]
15. Nanobodies as molecular imaging probes. Barakat S; Berksöz M; Zahedimaram P; Piepoli S; Erman B Free Radic Biol Med; 2022 Mar; 182():260-275. PubMed ID: 35240292 [TBL] [Abstract][Full Text] [Related]
16. Chemical shift assignments of a camelid nanobody against aflatoxin B Nie Y; Li S; Zhu J; Hu R; Liu M; He T; Yang Y Biomol NMR Assign; 2019 Apr; 13(1):75-78. PubMed ID: 30328057 [TBL] [Abstract][Full Text] [Related]
17. Development of a universal nanobody-binding Fab module for fiducial-assisted cryo-EM studies of membrane proteins. Bloch JS; Mukherjee S; Kowal J; Filippova EV; Niederer M; Pardon E; Steyaert J; Kossiakoff AA; Locher KP Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34782475 [TBL] [Abstract][Full Text] [Related]
18. Structure of Nanobody Nb23. Percipalle M; Hunashal Y; Steyaert J; Fogolari F; Esposito G Molecules; 2021 Jun; 26(12):. PubMed ID: 34207949 [TBL] [Abstract][Full Text] [Related]
19. Nanobodies as probes to investigate purinergic signaling. Eggers M; Rühl F; Haag F; Koch-Nolte F Biochem Pharmacol; 2021 May; 187():114394. PubMed ID: 33388283 [TBL] [Abstract][Full Text] [Related]
20. Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies. Romao E; Morales-Yanez F; Hu Y; Crauwels M; De Pauw P; Hassanzadeh GG; Devoogdt N; Ackaert C; Vincke C; Muyldermans S Curr Pharm Des; 2016; 22(43):6500-6518. PubMed ID: 27669966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]